Kathleen Rodgers

Dr. Rodgers is an internationally recognized authority on therapeutics development, the application of bench discoveries to clinical problems, and safety assessment prior to entrance of drugs into clinical development. She has expertise in preclinical discovery and development, formulation, pharmacology, developing and implementing toxicology plans, GMP manufacturing of complex formulations, writing of regulatory documents, and interacting with regulatory attorneys and the FDA. Dr. Rodgers has been a board-certified toxicologist for 25 years and her research has led to over 15 clinical trials in several disease states and the founding of three startup companies, helping to rapidly translate scientific discoveries into health outcome improvements.